The review of the objectives and action plans agreed at the 1998 UNGASS on Drugs has reached a critical stage. Following the thematic debate at the 2008 Commission on Narcotic Drugs, and the five expert working groups held in Vienna over the summer, the attention now moves to the political process of negotiating the text of a political declaration to be agreed at the high level meeting in March 2009.
TNI’s Martin Jelsma participated in the inaugural meeting in Rio de Janeiro of the Latin American Commission on Drugs and Democracyon April 30, 2008. Prominent members of the Commission are three Latin American former presidents: Fernando Henrique Cardoso from Brazil, César Gaviria from Colombia and Ernesto Zedillo from Mexico.
"It is time to develop a proper Latin American response that is detached from the ideology from the United States that has been common in the past decade," Martin Jelsma told the meeting. "It is potentially a good time to try because politically there is now more distance to US policies in a growing part of Latin America and to US domination in general."
Martin Jelsma, from the Transnational Institute, prepared an analysis for theLatin American Commission on Drugs and Democracy, explaining the drug policy situation in the European Union and the current state of debate in the United Nations agenda. The commission is an initiative born of former presidents Fernando Henrique Cardoso, from Brazil, César Gaviria, from Colombia and Ernesto Zedillo, from Mexico, to respond to concerns related to the problems of drug consumption and traffic in Latin America. The idea to constitute a commission capable of consolidating a debate concerning this problematic also responds to the necessity of reviewing the world drug policies in the scope of the United Nations, which began in March 2008.
Drug policy reform is currently higher on the international agenda than it has been in recent memory. With a United Nations General Assembly Special Session (UNGASS) on drugs set for 19-21 April 2016, the prominence of this issue will further increase. Significant legal and policy reforms at the national level have taken place in recent years that pose considerable challenges to the international legal framework for drug control, and beg important questions regarding states’ international legal obligations.
The "international community" presented an apparent unanimity in its endorsement of prohibitive drug control at the United Nations General Assembly Special Session (UNGASS) on drugs in 1998. The reality is that there is a longstanding conflict within the UN system between nations wanting to maintain the prohibition regime and those hoping for a more pragmatic approach.
The US delegation in Vienna continues to block any inclusion of harm reduction in the new Political Declaration – to be approved in March 2009 at the high-level segment of the 52nd session of the Commission on Narcotic Drugs. Three members of the US Congress have written a letter to the new US Ambassador to the UN, Susan Rice, to call for new instructions to be given to the delegation.
From 2-4 July I attended the “open-ended intergovernmental expert working group on international cooperation on the eradication of illicit drug crops and on alternative development” in Vienna as part of the Netherlands delegation. It was the third of the five working groups that will be organised, which are part of the UNGASS review process. These working groups are preparations for the high-level segment of the 52nd session of the Commission on Narcotic Drugs, which will take place in March 2009.
Drug law reform continues developing in the right direction in several Latin American and Caribbean countries. In Jamaica, for example, a law legalizing the cultivation and consumption of ganja for medicinal, religious and research purposes came into force, as well as the decriminalisation of possession for personal use. Jamaica also spoke out at the UN Thematic Debate in New York. On May 7th, the minister addressed the UN High Level Thematic Debate on international drug policy, highlighting Jamaica’s perspectives on drug control policies and participating in a debate that encourages open and inclusive discussions. Amongst the outcomes Jamaica would like to see from UNGASS is “the establishment of an Expert Advisory Group to review the UN drug policy control architecture, its system-wide coherence, its treaty inconsistencies and its legal tension with cannabis regulations.”
Drugs control is one of the most controversial issues of the late twentieth century. US-led efforts to wage a ‘war on drugs' have focused on wiping out production in developing countries, rather than tackling the demand for drugs in rich countries. Over time, eradication strategies have become increasingly militarised, and have led to human rights abuses and environmental degaradation. And the war has failed. The amount of drugs produced and drugs-linked crops cultivated have not decreased.
This briefing is published in the run-up to the United Nations General Assembly Special Session (UNGASS) on drugs, to be held in New York in June 1998. The UNGASS provides a rare opportunity to re-think current drugs efforts. Member states are being asked to endorse a plan, known as SCOPE, for the eradication of drugs-linked crops by 2008. Is SCOPE viable? And what impact would it have on poor farmers who grow drugs-linked crops to survive?
David Bewley-Taylor, Martin Jelsma, Christopher Hallam
16 June 2014
Scheduling is mostly prioritised in its repressive pole, though present debates are increasingly highlighting the need to modify the balance of the system in order to affirm the importance of the principle of health.
The International Drug Policy Consortium (IDPC) – of which TNI is a member – published a third version of its Advocacy Guide that provides an update on the emerging process for the review of global policies on controlled drugs being conducted under the auspices of the United Nations. It describes the latest situation on the planning for the review, and sets out the IDPC position on which issues need to be addressed in the review, and how these issues may be tackled in order to achieve a constructive outcome.
The International Drug Policy Consortium (IDPC) – of which TNI is a member – published a second version of its Advocacy Guide that provides an update on the emerging process for the review of global policies on controlled drugs being conducted under the auspices of the United Nations. It describes the latest situation on the planning for the review, and sets out the IDPC position on which issues need to be addressed in the review, and how these issues may be tackled in order to achieve a constructive outcome.
The Latin American Commission on Drugs and Democracy presented its conclusions at a press conference in Rio de Janeiro, on 11 February. Founded by former Presidents Fernando Henrique Cardoso (Brazil), César Gaviria (Colombia) and Ernesto Zedillo (Mexico), integrated by 17 independent members, the Commission assessed the limits and unwanted effects of the repressive policies of the "war on drugs" in Latin America.
State-level cannabis reforms have exposed the inability of the United States to abide by the terms of the legal bedrock of the global drug control system. It is calls for a conversation the US federal government wishes to avoid. The result is a new official position on the UN drugs treaties that, despite its seductively progressive tone, serves only to sustain the status quo and may cause damage beyond drug policy.
In a first analysis of the outcomes of the 2003 UNGASS mid-term review in April 2003, TNI concluded that the outcomes were very disappointing. The absence of significant progress over the past five years had not led to self-reflection and evaluation. The goals and targets of the UNGASS were simply re-affirmed. Most countries concentrated on a stock taking halfway of the implemented measures, without an honest analysis of the impact. The result is a distorted picture of virtual progress in order to justify to stay on the same course. The illusion is kept alive that reality will somehow fall into line with wishful thinking.
In April 2016, representatives of the world’s nations will gather to evaluate drug policy in a United Nations General Assembly Special Session (UNGASS). While prohibitionist policies are still the norm, a rising tide of voices are demanding evidence based responses that respect human rights, promote public health, and reduce crime.